Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Progyny, Inc. - Common Stock (NQ:PGNY)

22.75 +0.75 (+3.39%)
Streaming Delayed Price Updated: 11:11 AM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early... 
Via Benzinga
Why Progyny Shares Are Trading Higher Today
Progyny (NASDAQ: PGNY) shares are trading higher on Tuesday after the company reported better-than-expected Q4 results. 
Via Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Earnings Preview: Progyny
Via Benzinga
Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire... 
Via Benzinga
Zoom Is Zooming, But This Health-Tech Stock Is Doing Even Better
Big after-hours gains followed a strong day on Wall Street. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Progyny, Inc. Announces Fourth Quarter 2022 Results
From Progyny
Via GlobeNewswire
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Progyny, Inc.Investors to Inquire About Securities Class Action Investigation - PGNY
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report
From Progyny
Via GlobeNewswire
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
What Does Amazon's Acquisition of 1LifeMedical Mean To Investors?
After the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors? 
Via MarketBeat
Topics Initial Public Offering Regulatory Compliance
7 Stocks With a Forward P/E of 25 to Run Away From
Expensive stocks with all the warning signs of having a high a risk of missing expectations are some of the stocks to avoid. 
Via InvestorPlace
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
From Progyny
Via GlobeNewswire
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next Decade
Three-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candidates. 
Via The Motley Fool
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on... 
Via Benzinga
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
PGNY INVESTOR NOTICE: Rosen Law Firm Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
From The Rosen Law Firm, P.A.
Via Business Wire
Progyny Raises 2022 Financial Guidance
Shipments of Key Fertility Medication Have Resumed 
From Progyny
Via GlobeNewswire
Progyny, Inc. Announces Third Quarter 2022 Results
From Progyny
Via GlobeNewswire
A Preview Of Progyny's Earnings
Progyny (NASDAQ:PGNY) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Progyny will report... 
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
These healthcare businesses not only bring intriguing growth prospects but are already profitable. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.